131 related articles for article (PubMed ID: 11755235)
1. Synthesis and evaluation of antihypertensive activity of 1,8-naphthyridine derivatives. Part X.
Badawneh M; Ferrarini PL; Calderone V; Manera C; Martinotti E; Mori C; Saccomanni G; Testai L
Eur J Med Chem; 2001; 36(11-12):925-34. PubMed ID: 11755235
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 1,8-naphthyridine derivatives. Potential antihypertensive agents. II.
Da Settimo A; Ferrarini PL; Mori C; Primofiore G; Subissi A
Farmaco Sci; 1986 Nov; 41(11):827-38. PubMed ID: 2879740
[TBL] [Abstract][Full Text] [Related]
3. The role of NO-cGMP pathway and potassium channels on the relaxation induced by clonidine in the rat mesenteric arterial bed.
Pimentel AM; Costa CA; Carvalho LC; Brandão RM; Rangel BM; Tano T; Soares de Moura R; Resende AC
Vascul Pharmacol; 2007 May; 46(5):353-9. PubMed ID: 17258511
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
[TBL] [Abstract][Full Text] [Related]
5. Microwave assisted synthesis of 2-(4-substituted piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile as a new class of serotonin 5-HT3 receptor antagonists.
Mahesh R; Perumal RV; Pandi PV
Bioorg Med Chem Lett; 2004 Oct; 14(20):5179-81. PubMed ID: 15380223
[TBL] [Abstract][Full Text] [Related]
6. The synthesis and biological evaluation of a range of novel functionalized benzopyrans as potential potassium channel activators.
Tyrrell E; Tesfa KH; Greenwood I; Mann A
Bioorg Med Chem Lett; 2008 Feb; 18(3):1237-40. PubMed ID: 18191566
[TBL] [Abstract][Full Text] [Related]
7. [Design, synthesis and vasorelaxant activity of R, S-1-(substituted phenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazine derivatives].
Fu XZ; Tang L; Yuan M; Shi JS
Yao Xue Xue Bao; 2007 Jul; 42(7):735-40. PubMed ID: 17882957
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and pharmacological screening of novel antihypertensive agents using hybrid approach.
Bhandari SV; Bothara KG; Patil AA; Chitre TS; Sarkate AP; Gore ST; Dangre SC; Khachane CV
Bioorg Med Chem; 2009 Jan; 17(1):390-400. PubMed ID: 19036593
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of poly ADP-ribose polymerase-1 inhibitors. 2. Biological evaluation of aza-5[H]-phenanthridin-6-ones as potent, aqueous-soluble compounds for the treatment of ischemic injuries.
Ferraris D; Ko YS; Pahutski T; Ficco RP; Serdyuk L; Alemu C; Bradford C; Chiou T; Hoover R; Huang S; Lautar S; Liang S; Lin Q; Lu MX; Mooney M; Morgan L; Qian Y; Tran S; Williams LR; Wu QY; Zhang J; Zou Y; Kalish V
J Med Chem; 2003 Jul; 46(14):3138-51. PubMed ID: 12825952
[TBL] [Abstract][Full Text] [Related]
10. Some pyrrole substituted aryl pyridazinone and phthalazinone derivatives and their antihypertensive activities.
Demirayak S; Karaburun AC; Beis R
Eur J Med Chem; 2004 Dec; 39(12):1089-95. PubMed ID: 15571871
[TBL] [Abstract][Full Text] [Related]
11. Isosteviol acts on potassium channels to relax isolated aortic strips of Wistar rat.
Wong KL; Chan P; Yang HY; Hsu FL; Liu IM; Cheng YW; Cheng JT
Life Sci; 2004 Mar; 74(19):2379-87. PubMed ID: 14998715
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis and preliminary pharmacological screening of 2,4-disubstituted N,N-dialkyl-1,8-naphthyridine-3-carboxamides].
Di Braccio M; Roma G; Balbi A; Sottofattori E; Carazzone M
Farmaco; 1989 Sep; 44(9):865-81. PubMed ID: 2604838
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity.
Fernandes D; da Silva-Santos JE; Duma D; Villela CG; Barja-Fidalgo C; Assreuy J
Mol Pharmacol; 2006 Mar; 69(3):983-90. PubMed ID: 16326931
[TBL] [Abstract][Full Text] [Related]
14. Endothelium-dependent and -independent vasorelaxation by a theophylline derivative MCPT: roles of cyclic nucleotides, potassium channel opening and phosphodiesterase inhibition.
Lo YC; Tsou HH; Lin RJ; Wu DC; Wu BN; Lin YT; Chen IJ
Life Sci; 2005 Jan; 76(8):931-44. PubMed ID: 15589969
[TBL] [Abstract][Full Text] [Related]
15. Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers.
Cecchetti V; Calderone V; Tabarrini O; Sabatini S; Filipponi E; Testai L; Spogli R; Martinotti E; Fravolini A
J Med Chem; 2003 Aug; 46(17):3670-9. PubMed ID: 12904071
[TBL] [Abstract][Full Text] [Related]
16. Vasorelaxation induced by the new nitric oxide donor cis-[Ru(Cl)(bpy)(2)(NO)](PF(6)) is due to activation of K(Ca) by a cGMP-dependent pathway.
Lunardi CN; Vercesi JA; da Silva RS; Bendhack LM
Vascul Pharmacol; 2007; 47(2-3):139-44. PubMed ID: 17602893
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular pharmacological characterization of novel 2,3-dimethyl-2-butylamine derivatives in rats.
Chen YP; Qiu CR; Wang H
Life Sci; 2004 Sep; 75(17):2131-42. PubMed ID: 15312756
[TBL] [Abstract][Full Text] [Related]
18. Study on affinity profile toward native human and bovine adenosine receptors of a series of 1,8-naphthyridine derivatives.
Ferrarini PL; Betti L; Cavallini T; Giannaccini G; Lucacchini A; Manera C; Martinelli A; Ortore G; Saccomanni G; Tuccinardi T
J Med Chem; 2004 Jun; 47(12):3019-31. PubMed ID: 15163184
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antihypertensive activity evaluation of indole derivatives N-acetamido substituted.
Grasso S; Molica C; Monforte AM; Monforte P; Zappalà M; Monforte MT; Trovato A
Farmaco; 1995 Feb; 50(2):113-7. PubMed ID: 7766275
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying relaxation of rabbit aorta by BAY 41-2272, a nitric oxide-independent soluble guanylate cyclase activator.
Priviero FB; Baracat JS; Teixeira CE; Claudino MA; De Nucci G; Antunes E
Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):728-34. PubMed ID: 16173929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
